Ignite Creation Date:
2024-05-06 @ 8:12 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06294899
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-02-28
Brief Title:
CRP and Lung Ultrasound in Respiratory Evaluation
Sponsor:
Fundacio dInvestigacio en Atencio Primaria Jordi Gol i Gurina
Organization:
Fundacio dInvestigacio en Atencio Primaria Jordi Gol i Gurina
Study Overview
Official Title:
Evaluation of Point-of-Care Ultrasound Along With C-Reactive Protein-Point of Care Tests Impact on Clinical Decision-making and Perceived Usefulness in Routine Healthcare Use in Patients With Lower Respiratory Tract Infection Correlation Between C-Reactive Protein Concentrations and Lung Ultrasound Findings
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLURE
Brief Summary:
Lower respiratory tract infections LRTIs are one of the most common reasons for consultation in Primary Care centres Differentiating between viral and bacterial aetiologies can be challenging leading to inappropriate antibiotic prescribing Lung ultrasound LUS an imaging test that gained particular relevance since the beginning of the SARS-CoV-2 pandemic offers several advantages over the classic chest X-ray in detecting and monitoring LRTIs especially when pleural involvement exists
This study aims to correlate LUS findings with capillary blood C-Reactive Protein CRP values in patients with LRTIs evaluating LUS as a diagnostic tool and its impact on therapeutic decisions The descriptive observational study conducted from January 2024 to December 2026 in Lleida will include LRTI patients attending Primary Care centres By validating LUS as a rapid and non-invasive diagnostic tool unnecessary antibiotic prescriptions can be reduced promoting LUS as a complementary test in Primary Care consultations This will facilitate appropriate diagnosis and treatment decisions for patients with LRTIs enhancing the overall management of respiratory infections
This study aims to correlate LUS findings with capillary blood C-Reactive Protein CRP values in patients with LRTIs evaluating LUS as a diagnostic tool and its impact on therapeutic decisions The descriptive observational study conducted from January 2024 to December 2026 in Lleida will include LRTI patients attending Primary Care centres By validating LUS as a rapid and non-invasive diagnostic tool unnecessary antibiotic prescriptions can be reduced promoting LUS as a complementary test in Primary Care consultations This will facilitate appropriate diagnosis and treatment decisions for patients with LRTIs enhancing the overall management of respiratory infections
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None